Rekombinanter SARS-CoV-2 Spike S2 Antikörper

Produktnummer ABIN7271738

Der Human Monoklonal Anti-SARS-CoV-2 Spike S2 Antikörper wurde für validiert. Er ist geeignet, SARS-CoV-2 Spike S2 in Proben von SARS Coronavirus-2 (SARS-CoV-2) zu detektieren.

Kurzübersicht für Rekombinanter SARS-CoV-2 Spike S2 Antikörper (ABIN7271738)

Target: SARS-CoV-2 Spike S2 (SARS-CoV-2 S2)

Antikörpertyp: Recombinant Antibody

Reaktivität: SARS Coronavirus-2 (SARS-CoV-2)

Wirt: Human

Klonalität: Monoklonal

Konjugat: Dieser SARS-CoV-2 Spike S2 Antikörper ist unkonjugiert

Applikation: Bitte anfragen

Klon: AS86

Produktdetails anti-SARS-CoV-2 Spike S2 Antikörper

Verwendungszweck: Anti-SARS-CoV-2 Spike S2 protein Antibody, Human IgG4 (AS86)

Spezifität: This product is a specific antibody against SARS-CoV-2 Spike S2 protein. Cross-reactivity with S2 protein of other coronaviruses has not been tested.

Produktmerkmale: Recombinant Antibodies produced in CHO. Anti-SARS-CoV-2 Spike S2 protein Antibody, Human IgG4 (AS86) is isolated from a SARS-CoV-2 infected patient and is recombinantly produced from CHO cells.

Immunogen: Anti-SARS-CoV-2 Spike S2 protein Antibody, Human IgG4 (AS86) is isolated from a SARS-CoV-2 infected patient and is recombinantly produced from CHO cells.

Isotyp: IgG4

Anwendungsinformationen

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Powder

Lagerung: -20 °C

Informationen zur Lagerung: -20°C

Details zu SARS-CoV-2 Spike S2

Target: SARS-CoV-2 Spike S2 (SARS-CoV-2 S2)

Andere Bezeichnung: SARS-CoV-2 Spike S2

Substanzklasse: Viral Protein

Hintergrund: It's been reported that SARS-CoV-2 can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.